A randomized study on the use of thalidomide administered either in a continually route or in cycles in association with high dose dexamethasone in patients with refractory or relapsed multiple myeloma.

INTERVENTION: Trade Name: Thalidomide Product Name: NA Product Code: NA Pharmaceutical Form: Tablet INN or Proposed INN: Thalidomide Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 100‐ Trade Name: SOLDESAM*0,2% OS GTT 10ML Product Name: NA Product Code: NA Pharmaceutical Form: Oral solution INN or Proposed INN: Dexamethasone CAS Number: 2392‐39‐4 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 20‐ CONDITION: Multiple myeloma. ; MedDRA version: 6.1 Level: PT Classification code 10028228 PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range